XML 42 R32.htm IDEA: XBRL DOCUMENT
v3.23.2

STOCKHOLDERS' EQUITY (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2023
Stockholders' Equity Note [Abstract] |
Schedule of Compensation Cost on Net Earnings | The Company’s results for the three and six months ended June 30, 2023 and 2022 reflected the following stock-based compensation cost, and such compensation cost had the following effects on net earnings:
|  | Increase/(Decrease) for the |  | Increase/(Decrease) for the
|  | Three Months Ended June 30, |  | Six Months Ended June 30,
|  | 2023 |  | 2022 |  | 2023 |  | 2022
Cost of sales |  | $ | 545 |  |  | $ | 277 |  |  | $ | 959 |  |  | $ | 676 |
Operating expenses |  | 3,203 |  |  | 3,535 |  |  | 7,559 |  |  | 6,213 |
Net earnings |  | (2,881) |  |  | (2,933) |  |  | (6,563) |  |  | (5,312) |
Schedule of Stock Option Activity | Option activity for the six months ended June 30, 2023 and 2022 is summarized below:
For the Six Months Ended June 30, 2023 |  | Shares (000s) |  | Weighted Average Exercise Price |  | Aggregate Intrinsic Value |  | Weighted Average Remaining Contractual Term
Outstanding as of December 31, 2022 |  | 1,045 |  |  | $ | 99.82 |  |  | $ | 27,221 |  |  |
Granted |  | 109 |  |  | 138.09 |  |  |  |  |
Exercised |  | (46) |  |  | 83.43 |  |  |  |  |
Forfeited |  | (11) |  |  | 131.79 |  |  |  |  |
Canceled |  | (1) |  |  | 138.07 |  |  |  |  |
Outstanding as of June 30, 2023 |  | 1,096 |  |  | $ | 103.96 |  |  | $ | 35,430 |  |  | 6.2
Exercisable as of June 30, 2023 |  | 728 |  |  | $ | 87.95 |  |  | $ | 34,170 |  |  | 4.8
For the Six Months Ended June 30, 2022 |  | Shares (000s) |  | Weighted Average Exercise Price |  | Aggregate Intrinsic Value |  | Weighted Average Remaining Contractual Term
Outstanding as of December 31, 2021 |  | 867 |  |  | $ | 88.19 |  |  | $ | 69,711 |  |  |
Granted |  | 109 |  |  | 138.07 |  |  |  |  |
Exercised |  | (18) |  |  | 72.74 |  |  |  |  |
Forfeited |  | (6) |  |  | 120.36 |  |  |  |  |
Canceled |  | — |  |  | — |  |  |  |  |
Outstanding as of June 30, 2022 |  | 952 |  |  | $ | 93.99 |  |  | $ | 34,907 |  |  | 6.4
Exercisable as of June 30, 2022 |  | 666 |  |  | $ | 81.11 |  |  | $ | 32,409 |  |  | 5.4
Schedule of Other Information Pertaining to Stock Option Activity | Other information pertaining to option activity during the three and six months ended June 30, 2023 and 2022 is as follows:
|  | Three Months Ended June 30, |  | Six Months Ended June 30,
|  | 2023 |  | 2022 |  | 2023 |  | 2022
Weighted-average fair value of options granted |  | $ | — |  |  | $ | — |  |  | $ | 40.91 |  |  | $ | 40.26 |
Total intrinsic value of stock options exercised ($000s) |  | $ | 597 |  |  | $ | 495 |  |  | $ | 2,181 |  |  | $ | 1,149 |
Schedule of Non-vested Restricted Stock Activity | Non-vested restricted stock activity for the six months ended June 30, 2023 and 2022 is summarized below:
|  | Six Months Ended June 30,
|  | 2023 |  | 2022
|  | Shares (000s) |  | Weighted Average Grant Date Fair Value |  | Shares (000s) |  | Weighted Average Grant Date Fair Value
Non-vested balance as of December 31 |  | 122 |  |  | $ | 124.42 |  |  | 166 |  |  | $ | 99.70 |
Granted |  | 39 |  |  | 137.48 |  |  | 34 |  |  | 137.74 |
Vested |  | (32) |  |  | 110.95 |  |  | (77) |  |  | 80.84 |
Forfeited |  | (4) |  |  | 128.06 |  |  | (3) |  |  | 116.73 |
Non-vested balance as of June 30 |  | 125 |  |  | $ | 131.76 |  |  | 120 |  |  | $ | 122.03 |
Schedule of Non-vested Performance Share Activity | Non-vested performance share activity for the six months ended June 30, 2023 and 2022 is summarized below:
|  | Six Months Ended June 30,
|  | 2023 |  | 2022
|  | Shares (000s) |  | Weighted Average Grant Date Fair Value |  | Shares (000s) |  | Weighted Average Grant Date Fair Value
Non-vested balance as of December 31 |  | 70 |  |  | $ | 127.69 |  |  | 69 |  | $ | 110.72 |
Granted |  | 42 |  |  | 139.66 |  |  | 39 |  | 114.22
Vested |  | (36) |  |  | 98.84 |  |  | (35) |  | 53.17
Forfeited |  | — |  |  | — |  |  | (3) |  | 84.09
Non-vested balance as of June 30 |  | 76 |  |  | $ | 135.25 |  |  | 70 |  | $ | 127.69 |

X
- References No definition available. + Details
Name: | bcpc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueAndGrantDateIntrinsicValueTableTextBlock
Namespace Prefix: | bcpc_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested performance-based units. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year. + References No definition available. + Details
Name: | us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration